Wenjie Zhu
321 Zhongshan Rd
Nanjing, 210008, China
Nanjing, 210008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Efficacy, Safety, and Biomarker Analysis of Toripalimab Monoclonal Antibody Combined With Gemcitabine and Cisplatin Chemotherapy as Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: A Phase II Clinical Trial.
Journal: The Journal of urology
Published: February 17, 2026
Clonotype-Resolved Single-Cell Multi-Omics Unlocks the Profile of Tumor-Infiltrating CD39⁺CD8⁺ T Cells and Enables Adoptive Cell Therapy for Solid Tumor.
Journal: International journal of biological sciences
Published: December 22, 2025
Y-Polyp: research on devices for detecting colorectal polyps with limited samples.
Journal: BMC medical imaging
Published: May 11, 2024
Patient-derived Immunocompetent Tumor Organoids: A Platform for Chemotherapy Evaluation in the Context of T-cell Recognition.
Journal: Angewandte Chemie (International ed. in English)
Published: November 19, 2023
Loss of macrophage TSC1 exacerbates sterile inflammatory liver injury through inhibiting the AKT/MST1/NRF2 signaling pathway.
Journal: Cell death & disease
Published: November 01, 2023
Glutamine supplementation improves the activity and immunosuppressive action of induced regulatory T cells in vitro and in vivo.
Journal: Transplant immunology
Published: October 12, 2023
ULK1 Mediated Autophagy-Promoting Effects of Rutin-Loaded Chitosan Nanoparticles Contribute to the Activation of NF-κB Signaling Besides Inhibiting EMT in Hep3B Hepatoma Cells.
Journal: International journal of nanomedicine
Published: October 04, 2023
ALOX5 deficiency contributes to bladder cancer progression by mediating ferroptosis escape.
Journal: Cell death & disease
Published: August 31, 2023
Prognostic and immunological role of Asporin across cancers and exploration in bladder cancer.
Journal: Gene
Published: April 20, 2023
The combination of oxaliplatin and anti-PD-1 inhibitor promotes immune cells infiltration and enhances anti-tumor effect of PD-1 blockade in bladder cancer.
Journal: Frontiers in immunology
Published: November 26, 2022
Antifungal immunity mediated by C-type lectin receptors may be a novel target in immunotherapy for urothelial bladder cancer.
Journal: Frontiers in immunology
Published: April 02, 2022
Last Updated: 09/26/2026